• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zymeworks Inc. - Common Stock (NY:ZYME)

N/A UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 5.950 (3)
Ask (Size) 6.750 (1)
Prev. Close 6.430
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Zymeworks Announces Participation in Upcoming Investor Conferences
May 28, 2024
From Zymeworks Inc.
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify and Encourages Investors to Contact the Firm
May 19, 2024
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

More News

Read More
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME)
May 16, 2024
From Kirby McInerney LLP
Via Business Wire
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
May 07, 2024
Via Benzinga
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 02, 2024
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
April 30, 2024
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
April 11, 2024
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
April 08, 2024
From Zymeworks Inc.
Via GlobeNewswire
ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks Stockholders and Encourages Investors to Contact the Firm
April 03, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)
April 02, 2024
From Kirby McInerney LLP
Via GlobeNewswire
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
March 28, 2024
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
March 27, 2024
From Zymeworks Inc.
Via GlobeNewswire
Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade
March 08, 2024
Via InvestorPlace
ZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023
March 06, 2024
Via InvestorPlace
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
March 06, 2024
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
March 05, 2024
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
February 27, 2024
From Zymeworks Inc.
Via GlobeNewswire
Earnings Scheduled For March 6, 2024
March 06, 2024
Via Benzinga
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
February 22, 2024
Via InvestorPlace
Last Call! 7 Small-Cap Stocks Ready to Explode in Value
February 20, 2024
Via InvestorPlace
Zymeworks - Analysts Project A Big Turnaround
February 20, 2024
Via Talk Markets
7 Small-Cap Stocks With Significant Upside Potential in 2024
February 15, 2024
Via InvestorPlace
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
February 14, 2024
From Zymeworks Inc.
Via GlobeNewswire
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer
February 09, 2024
Via Investor Brand Network
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
February 08, 2024
From Zymeworks Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Zymeworks Inc. - Common Stock publicly traded?
Yes, Zymeworks Inc. - Common Stock is publicly traded.
What exchange does Zymeworks Inc. - Common Stock trade on?
Zymeworks Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Zymeworks Inc. - Common Stock?
The ticker symbol for Zymeworks Inc. - Common Stock is ZYME on the New York Stock Exchange
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap